Immunoglobulins in primary antibody deficiency : should they also be used in sepsis and other indications?

Immunoglobulin is a blood product prepared from the plasma of healthy donors. The therapeutic use of polyvalent immunoglobulins is an established therapy in primary antibody deficiencies, in idiopathic thrombocytopenic purpura (ITP) and in Guillain-Barré syndrome. However, there is an ongoing debate about the efficacy of polyvalent immunoglobulins as adjunctive therapy for sepsis. The paper presented here critically discusses the modern studies investigating the use of immunoglobulins in different diseases. The main focus is the use of immunoglobulins in patients with sepsis or septic shock.

Medienart:

Artikel

Erscheinungsjahr:

2007

Erschienen:

2007

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Der Internist - 48(2007), 11 vom: 29. Nov., Seite 1297-302, 1304

Sprache:

Deutsch

Weiterer Titel:

Immunglobuline bei Antikörpermangelsyndrom: Einsatz auch bei Sepsis und anderen Indikationen?

Beteiligte Personen:

Kluge, S [VerfasserIn]
de Heer, G [VerfasserIn]
Nierhaus, A [VerfasserIn]
Kreymann, G [VerfasserIn]

Themen:

English Abstract
Journal Article
Review

Anmerkungen:

Date Completed 14.04.2008

Date Revised 20.10.2021

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM17405937X